{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:33:58Z","timestamp":1760747638719,"version":"build-2065373602"},"reference-count":29,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2023,5,1]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hexanucleotide repeat expansions of <jats:italic>C9ORF72<\/jats:italic> account for a significant proportion of autosomal dominant neurodegenerative diseases in the amyotrophic lateral sclerosis (ALS)\u2013frontotemporal dementia spectrum. In the absence of a family history, clinical identification of such patients remains difficult. We aimed to identify differences in demographics and clinical presentation between patients with <jats:italic>C9ORF72<\/jats:italic> gene-positive ALS (C9pALS) versus <jats:italic>C9ORF72<\/jats:italic> gene-negative ALS (C9nALS), to aid identification of these patients in the clinic and examine differences in outcomes including survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed the clinical presentations of 32 patients with C9pALS and compared their characteristics with a cohort of 46 patients with C9nALS from the same tertiary neurosciences centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with C9pALS more commonly presented with mixed upper and lower motor signs (C9pALS 87.5%, C9nALS 65.2%; p=0.0352), but less frequently presented with purely upper motor neuron signs (C9pALS 3.1%, C9nALS 21.7%; p=0.0226). The C9pALS cohort had a higher frequency of cognitive impairment (C9pALS 31.3%, C9nALS 10.9%; p=0.0394) and bulbar disease (C9pALS 56.3%, C9nALS 28.3%; p=0.0186). There were no differences between cohorts in age at diagnosis, gender, limb weakness, respiratory symptoms, presentation with predominantly lower motor neuron signs or overall survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Analysis of this ALS clinic cohort at a UK tertiary neurosciences centre adds to the small but growing understanding of the unique clinical features of patients with C9pALS. In the age of precision medicine with expanding opportunities to manage genetic diseases with disease-modifying therapies, clinical identification of such patients is increasingly important as focused therapeutic strategies become available.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmg-2022-109016","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:25:00Z","timestamp":1683897900000},"page":"1016-1020","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotypical differences of <i>C9ORF72<\/i> gene-positive and negative amyotrophic lateral sclerosis: a comparative case series"],"prefix":"10.1136","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-1374","authenticated-orcid":false,"given":"Laura Michelle","family":"White","sequence":"first","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Boardman","sequence":"additional","affiliation":[{"name":"Royal Preston Hospital, Preston, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lilleker","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"},{"name":"Centre for Musculoskeletal Research, The University of Manchester School of Biological Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Chaouch","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haga","family":"Kargwell","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ealing","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Hamdalla","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"2025101712041933000_60.10.1016.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.224501"},{"key":"2025101712041933000_60.10.1016.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.010"},{"key":"2025101712041933000_60.10.1016.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr365"},{"key":"2025101712041933000_60.10.1016.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70014-5"},{"key":"2025101712041933000_60.10.1016.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr366"},{"key":"2025101712041933000_60.10.1016.6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00415-022-11433-z","article-title":"Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis","volume":"270","author":"Colombo","year":"2023","journal-title":"J Neurol"},{"key":"2025101712041933000_60.10.1016.7","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22211"},{"key":"2025101712041933000_60.10.1016.8","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000665","article-title":"Als in Finland: major genetic variants and clinical characteristics of patients with and without the C9orf72 hexanucleotide repeat expansion","volume":"8","author":"Laaksovirta","year":"2022","journal-title":"Neurol Genet"},{"key":"2025101712041933000_60.10.1016.9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00415-022-11426-y","article-title":"Factors predicting disease progression in C9orf72 ALS patients","volume":"270","author":"Mandrioli","year":"2023","journal-title":"J Neurol"},{"key":"2025101712041933000_60.10.1016.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0937-5"},{"key":"2025101712041933000_60.10.1016.11","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00485"},{"key":"2025101712041933000_60.10.1016.12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/WNL.0000000000003067","article-title":"Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population","volume":"87","author":"Umoh","year":"2016","journal-title":"Neurology"},{"key":"2025101712041933000_60.10.1016.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182661d14"},{"key":"2025101712041933000_60.10.1016.14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/21678421.2013.765485","article-title":"Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72","volume":"14","author":"Snowden","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025101712041933000_60.10.1016.15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.neurobiolaging.2012.02.011","article-title":"C9Orf72 hexanucleotide repeat expansions in the Italian sporadic ALS population","volume":"33","author":"Sabatelli","year":"2012","journal-title":"Neurobiol Aging"},{"key":"2025101712041933000_60.10.1016.16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnins.2020.00316","article-title":"Clinical phenotype and inheritance in patients with C9orf72 hexanucleotide repeat expansion: results from a large French cohort","volume":"14","author":"Esselin","year":"2020","journal-title":"Front Neurosci"},{"key":"2025101712041933000_60.10.1016.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303507"},{"key":"2025101712041933000_60.10.1016.18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314093"},{"key":"2025101712041933000_60.10.1016.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70261-7"},{"key":"2025101712041933000_60.10.1016.20","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.neurobiolaging.2013.06.009","article-title":"Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study","volume":"34","author":"Debray","year":"2013","journal-title":"Neurobiol Aging"},{"key":"2025101712041933000_60.10.1016.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"2025101712041933000_60.10.1016.22","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536"},{"key":"2025101712041933000_60.10.1016.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2016.04.005"},{"key":"2025101712041933000_60.10.1016.24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.235952"},{"key":"2025101712041933000_60.10.1016.25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mus.23496","article-title":"Clinical evolution of pure upper motor neuron disease\/dysfunction (PUMMD)","volume":"47","author":"D\u2019Amico","year":"2013","journal-title":"Muscle Nerve"},{"key":"2025101712041933000_60.10.1016.26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/mus.21565","article-title":"Progressive muscular atrophy and other lower motor neuron syndromes of adults","volume":"41","author":"Rowland","year":"2010","journal-title":"Muscle Nerve"},{"key":"2025101712041933000_60.10.1016.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c1dea3"},{"key":"2025101712041933000_60.10.1016.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011093"},{"key":"2025101712041933000_60.10.1016.29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2022-109016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:04:28Z","timestamp":1760727868000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2022-109016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/jmg-2022-109016"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2022-109016","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}